Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term, Sustainable Growth and Provides Update on ELEVIDYS Label

Go back to Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term, Sustainable Growth and Provides Update on ELEVIDYS Label
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 20.14 --0 (-0%)
Previous Close $20.14    52 Week High $63.73 
Open $20.14    52 Week Low $8.00 
Day High $20.14    P/E N/A 
Day Low $20.14    EPS $-5.69 
Volume 1,776